Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 1, January, p. 19–24

doi: 10.17219/acem/76870

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Vitamin C may exert variable effects on viability and proliferation of HeLa cells exhibiting high and low chromosomal instability

Aastha Sindhwani1,B,C, Sasikala Muthusammy1,B,C, Alka Bhatia1,A,C,D,E,F

1 Department of Experimental Medicine & Biotechnology, Postgraduate Institute of Medical Education & Research, Chandigarh, India

Abstract

Background. Chromosomal instability (CIN), defined as abnormality in chromosome structure or number, is the hallmark of malignancies. The role of vitamin C in cancer treatment is controversial and its effect on CIN is still an open field of research. In this work, we tried to study the effect of high-dose L-ascorbic acid (L-AA) on CIN-induced (CINhi = CIN high) and non-CIN-induced (CINlo = CIN low) cervical cancer cells.
Objectives. The aim of this study was to explore the effect of high-dose L-AA on CIN in the cervical cancer cell line (HeLa) cells.
Material and Methods. The HeLa cells (CINhi and CINlo) were treated with 2 doses (5 mM and 8 mM) of L-AA for 24 h and 48 h. They were then analyzed by micronucleus (MN) scoring, cell ploidy and flow cytometry, the latter regarding γH2AX expression. Cell viability was assessed by the methylthiazol tetrazolium (MTT) and Annexin V assays.
Results. Treatment of CINhi cells with L-AA led to a decrease in MN score (colchicine – 71.5 ±4.95, 67.5 ±0.71; L-AA (5 mM) – 49 ±7.07, 46.5 ±4.95; L-AA (8 mM) – 42 ±9.89, 41 ±1.41, at 24 h and 48 h, respectively; p < 0.05). Treatment of CINlo cells with L-AA resulted in increased MN score (5 mM – 45 ±7.07, 36 ±4.24; 8 mM – 34.5 ±4.95, 31 ±1.41, at 24 h and 48 h, respectively; control – 15.5 ±0.71, 12.5 ±0.71; p < 0.05) and reduction in cancer cell viability (control – 100%; L-AA (5 mM) – 76.32% ±28.73, 72.74% ±20.30; L-AA (8 mM) – 66.14% ±19.13, 66.99% ±19.99, at 24 h and 48 h, respectively; p < 0.05). The expression of γH2AX was high in both groups at 48 h (mean CINhi = 19.42%, CINlo = 21.14%; control = 1.19% and 1.58%, respectively) with the 8 mM dose of L-AA.
Conclusion. L-ascorbic acid was found to have a differential effect on CINhi and CINlo HeLa cells, which may be due to differences in oxidation status of these 2 categories.

Key words

cancer, vitamin C, chromosomal instability

References (18)

  1. van Wely KM, Martinez CA. Linking stem cells to chromosomal instability. Oncoimmunol. 2012;1(2):195–200.
  2. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976;73(10):3685–3689.
  3. Hoffer LJ, Robitaille L, Zakarian R, et al. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: A phase I-II clinical trial. PLoS ONE. 2015;10(4): e0120228. doi: 10.1371/journal.pone.0120228
  4. Doskey CM, Buranasudja V, Wagner BA, et al. Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy. Redox Biol. 2016;10:274–284.
  5. Yun J, Mullarky E, Lu C, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015;350(6266):1391–1396.
  6. Bonuccelli G, De Francesco EM, de Boer R, Tanowitz HB, Lisanti MP. NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of vitamin C and CAPE as natural products targeting “stemness”. Oncotarget. 2017; 8(13):20667–20678. doi: 10.18632/oncotarget.1540
  7. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014;6(222):222ra18. doi: 10.1126/scitranslmed.3007154
  8. Kundu LM, Ray S. Mitotic abnormalities and micronuclei inducing potentials of colchicine and leaf aqueous extracts of Clerodendrum viscosum Vent. in Allium cepa root apical meristem cells. International Journal of Cytology, Cytosystematics and Cytogenetics. 2016;70:7–14.
  9. Nefic H. The genotoxicity of vitamin C in vitro. Bosn J Basic Med Sci. 2008;8(2):142–146.
  10. Madhuri K, Vani K, Syed R, Alshatwi AA. Role of ascorbic acid as an antioxidant in gastric cancer patients in South Indian population. Int J Pharm Pharm Sci. 2011;3:179–181.
  11. Azqueta A, Costa S, Lorenzo Y, Bastani NE, Collins AR. Vitamin C in cultured human (HeLa) cells: Lack of effect on DNA protection and repair. Nutrients. 2013;5(4):1200–1217.
  12. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell. 2013;11(1):25–36.
  13. Thomas CG, Vezyraki PE, Kalfakakou VP, Evangelou AM. Vitamin C transiently arrests cancer cell cycle progression in S phase and G2/M boundary by modulating the kinetics of activation and the subcellular localization of Cdc25C phosphatase. J Cell Physiol. 2005;205(2):310–318.
  14. Guerriero E, Sorice A, Capone F, et al. Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines. PLoS ONE. 2014;9(12):e115287. doi: 10.1371/journal.pone.0115287
  15. Hahm E, Jin DH, Kang JS, et al. The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma. J Cell Biochem. 2007;102(4):1002–1010.
  16. Sajadian SO, Tripura C, Samani FS, et al. Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7. Clin Epigenetics. 2016;8:46. doi: 10.1186/s13148-016-0213-6
  17. Verrax J, Cadrobbi J, Delvaux M, et al. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death: Basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem. 2003;38(5):451–457.
  18. Chen Q, Espey MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102(38):13604–13609.
© Wroclaw Medical University